IRIS PubliCatt

Grieco, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.606
NA - Nord America 6.020
AS - Asia 1.335
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 26
AF - Africa 22
SA - Sud America 16
Totale 14.054
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.990
DE - Germania 2.832
SE - Svezia 1.297
CN - Cina 912
UA - Ucraina 692
IT - Italia 551
IE - Irlanda 356
GB - Regno Unito 222
FR - Francia 220
FI - Finlandia 185
TR - Turchia 158
IN - India 139
PL - Polonia 62
RU - Federazione Russa 58
BE - Belgio 39
IR - Iran 26
AU - Australia 25
HK - Hong Kong 25
EU - Europa 22
SG - Singapore 22
JP - Giappone 21
CA - Canada 16
RO - Romania 15
CH - Svizzera 12
PT - Portogallo 10
CI - Costa d'Avorio 9
NL - Olanda 9
BR - Brasile 8
IL - Israele 8
CZ - Repubblica Ceca 7
ES - Italia 7
HU - Ungheria 6
BZ - Belize 5
DK - Danimarca 5
ID - Indonesia 5
MK - Macedonia 5
CL - Cile 4
EE - Estonia 4
MX - Messico 4
NZ - Nuova Zelanda 4
A2 - ???statistics.table.value.countryCode.A2??? 3
EG - Egitto 3
GR - Grecia 3
MY - Malesia 3
NG - Nigeria 3
PA - Panama 3
PE - Perù 3
VN - Vietnam 3
AT - Austria 2
KR - Corea 2
NO - Norvegia 2
PR - Porto Rico 2
SC - Seychelles 2
SD - Sudan 2
TH - Thailandia 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BG - Bulgaria 1
DJ - Gibuti 1
GE - Georgia 1
HR - Croazia 1
KW - Kuwait 1
MA - Marocco 1
MC - Monaco 1
MD - Moldavia 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
PH - Filippine 1
PK - Pakistan 1
RS - Serbia 1
SA - Arabia Saudita 1
TW - Taiwan 1
Totale 14.054
Salva come PNG Salva come JPEG
Città #
Chandler 1.321
Ashburn 430
Jacksonville 405
Dublin 354
San Mateo 330
Nanjing 232
Ann Arbor 223
Wilmington 193
Nürnberg 180
Boston 175
Cattolica 151
Izmir 151
Houston 148
New York 145
Dearborn 139
Princeton 121
Woodbridge 119
Munich 104
Beijing 100
Marseille 98
Nanchang 98
Milan 80
Seattle 70
Redwood City 67
Lawrence 66
Rome 64
Redmond 63
Boardman 59
Fairfield 57
Hebei 55
Kraków 55
Chicago 53
Tianjin 52
Mountain View 46
Helsinki 45
Bremen 44
Shenyang 43
Kunming 40
Brussels 39
University Park 39
Jiaxing 36
Norwalk 36
Zhengzhou 36
Changsha 35
Hangzhou 31
San Jose 30
Augusta 28
Fremont 28
Los Angeles 28
Jinan 25
Hong Kong 24
Washington 24
Cambridge 22
Guangzhou 21
Falls Church 20
Pune 20
Simi Valley 20
Andover 19
Lancaster 17
Saint Petersburg 17
Leawood 15
Ningbo 14
Lanzhou 13
London 13
San Diego 13
Taizhou 13
Detroit 12
Indiana 10
Kish 10
Singapore 10
Abidjan 9
Changchun 9
Buffalo 8
Campagna 8
Edinburgh 8
Shanghai 8
Atlanta 7
Busto Arsizio 7
Hefei 7
Phoenix 7
Provo 7
Tappahannock 7
Warsaw 7
Zurich 7
Brno 6
Chengdu 6
Las Vegas 6
Portland 6
San Francisco 6
Albuquerque 5
Belize City 5
Chiswick 5
Esslingen am Neckar 5
Monmouth Junction 5
Paris 5
Stockholm 5
Tokyo 5
Toronto 5
Amsterdam 4
Auckland 4
Totale 7.083
Salva come PNG Salva come JPEG
Nome #
Gastrointestinal amyloidosis: a case of chronic diarrhoea. 263
Practice guidelines for the treatment of hepatitis C: recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting. 253
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 202
A phase II study of sunitinib in advanced hepatocellular carcinoma 200
13C-methionine breath tests for mitochondrial liver function assessment. 198
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 176
Abdominal angina due to recurrence of cancer of the papilla of vater: a case report. 172
-Hepatic steatosis and vascular disease 164
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 156
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 149
134C-breath tests in the study of mitochondrial liver function 144
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 144
Severe veno-occlusive disease after autologous peripheral blood stem cell transplantation for high-grade non-Hodgkin lymphoma: report of a successfully managed case and a literature review of veno-occlusive disease. 143
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 140
Prospective study of hepatitis B virus reactivation in patients with hematological malignancies 139
Radiofrequency ablation plus drug-eluting beads transcatheter arterial chemoembolization for the treatment of single large hepatocellular carcinoma 133
13C-breath tests in the study of microsomial liver function 132
Effect of sildenafil on diabetic gastropathy. 129
recurrent acute hepatitis associated with use of cetrizine 123
Safety and efficacy profile of G-CSF therapy in patients with acute on chronic liver failure 122
Epicardial fat thickness correlates with body fat stores, insulin resistance and alanine aminotransferase in patients affected by nonalcoholic steatohepatitis (NASH) 122
Contrast-enhanced ultrasound assessment of arterial vascularization of small nodules arising in the cirrhotic liver 121
13C-methionine breath tests for mitochondrial liver function assessment 119
The Effect of CYP, GST, and SULT Polymorphisms and Their Interaction with Smoking on the Risk of Hepatocellular Carcinoma 114
gc) Celiac disease in the 21st century: issues of under- and over-diagnosis 113
[Oxidative stress in metabolic syndrome and nonalcoholic steatohepatitis. Is it possible a role for vitamins in clinical practice?] 112
Vanishing-recurrent benign liver lesions 109
13C-breath tests in the study of mitochondrial liver function 108
Potential use of liver function breath tests in the clinical practice. 107
Clopidogrel-induced neutropenia after coronary stenting: is cilostazol a good alternative? 106
Hepatocellular carcinoma treated by conventional transarterial chemoembolization in field-practice: serum sodium predicts survival 106
[The treatment of hepatocellular carcinoma: an update] 102
Quando e perché fermarsi nelle terapie: l’opinione del clinico e del bioeticista sui casi di HCC avanzato. 102
Faecal calprotectin concentrations in untreated coeliac patients 101
Hepatitis C in the elderly: A multicentre cross-sectional study by the Italian Association for the Study of the Liver 99
A "systems medicine" approach to the study of non-alcoholic fatty liver disease 98
Noninvasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). 97
Nonalcoholic fatty liver disease is associated with increased GHBP and reduced GH/IGF-I levels 97
Tromboembolism and breast cancer: the hidden risk for patient and physician 97
gastroesophageal reflux disease: facts and uncertaines 96
Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre. 96
-Fatty liver and drugs 95
Cystic lymphangioma of the mesentery and hyposplenism in celiac disease. 93
Liver resection for hepatocellular carcinoma in patient with situs inversus viscerum 93
Evaluation of the albumin-gamma-glutamyl transferase isoenzyme as a diagnostic marker of hepatocellular carcinoma-complicating liver cirrhosis. 92
Cryoglobulinemia: a true internistic disease? 91
L'insufficienza epatica: algoritmi diagnostici e trattamenti medici 91
A case-control study on the effects of the apolipoprotein E genotypes in nonalcoholic fatty liver disease 91
Bone metastasis in hepatocellular carcinoma. A report of five cases and a review of the literature. 89
FAECAL CALPROTECTIN CONCENTRATIONS IN UNTREATED CELIAC PATIENTS 88
Comment on "the role of endoscopic ultrasound in the evaluation of chronic mesenteric ischaemia" 87
A case-control study on the effect of metabolic gene polymorphisms, nutrition, and their interaction on the risk of non-alcoholic fatty liver disease 87
Liver transplantation in patients with alcoholic liver disease: A retrospective study 86
Liver metastases of endocrine tumour associated with multiple endocrine neoplasia type 1: a sustained response to interferon therapy or a peculiar benign course? 85
[Natural history, diagnosis and treatment of chronic hepatitis B and C in hemodialysis patients] 85
Intestinal permeability after Mediterranean diet and low-fat diet in non-alcoholic fatty liver disease 83
Severe giant cell arteritis associated with essential thrombocythaemia. 82
Genetic susceptibility of increased intestinal permeability is associated with progressive liver disease and diabetes in patients with non-alcoholic fatty liver disease 82
Hepatic mitochondrial beta-oxidation in patients with nonalcoholic steatohepatitis assessed by 13C-octanoate breath test. 80
-Nonalcoholic fatty liver disease: defining a common problem 79
Alcoholic and nonalcoholic forms of fatty liver disease. 78
Gallstone disease is associated with more severe liver damage in patients with non-alcoholic Fatty liver disease 78
Antipyrine clearance in chronic and neoplastic liver diseases: a study of 518 patients. 78
High Prevalence and Gender-Related Differences of Gastrointestinal Manifestations in a Cohort of DM1 Patients: A Perspective, Cross-Sectional Study 78
Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets 78
Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: a randomized controlled trial 77
Advanced colon cancer: staging and prognosis by CEA test 77
Gut-liver axis and microbiota in NAFLD: insight pathophysiology for novel therapeutic target 77
Braised liver with herbs: the risks of naturopathic hepatoprotection. 76
Severe acute hepatitis after resumption of interferon-Beta therapy for multiple sclerosis: a word of caution. 76
Low-dose lactose in drugs neither increases breath hydrogen excretion nor causes gastrointestinal symptoms. 73
Is coeliac disease a confounding factor in the diagnosis of NASH? 72
Socio-demographic determinants of coinfections by HIV, hepatitis B and hepatitis C viruses in central Italian prisoners. 72
Review article: breath testing for human liver function assessment. 72
A giant calcified hepatic mass 72
Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk 72
Prevalence and Risk Factors Associated with Use of QT-Prolonging Drugs in Hospitalized Older People 72
A peculiar cause of small-bowel intussusception and iron deficiency anaemia 71
An update on clinical applications of hepatospecific contrast media in magnetic resonance imaging of liver parenchyma 71
Gender affects 13C-ketoisocaproic acid breath test 70
Multimorbidity and polypharmacy in the elderly: lessons from REPOSI 70
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 69
Contrast-enhanced ultrasound in the short-term evaluation of hepatocellular carcinoma after locoregional treatment 69
Impairment of recent thymic emigrants in HCV infection. 68
A case-control study on the effect of metabolic gene polymorphisms, nutrition, and their interaction on the risk of non-alcoholic fatty liver disease 67
A "systems medicine" approach to the study of non-alcoholic fatty liver disease 67
Drug-induced hepatitis 66
Nutritional aspects in patients with non-alcoholic steatohepatitis (NASH) 66
Impact of new DAA therapy on real clinical practice: A multicenter region-wide cohort study 66
Acute fatty liver after malaria prophylaxis with mefloquine 65
The diagnostic performance of PIVKA-II in metabolic and viral hepatocellular carcinoma: A pilot study 65
Ventricular thrombosis during sorafenib therapy for advanced hepatocellular carcinoma 64
Drug-induced liver injury 2017: the diagnosis is not easy but always to keep in mind 64
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma 64
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 64
"tear-drop shaped" HCC 62
Glucokinase Regulatory Protein Gene Polymorphism Affects Liver Fibrosis in Non-Alcoholic Fatty Liver Disease 62
Focus on fatty liver in clinical practice 61
NON ALCOHOLIC STEATOHEPATITIS (NASH) INDUCED BY CARBAMAZEPINE AND VARIEGATE PORPHYRIA 61
A case of esomeprazole-induced transient diabetes and hepatitis: the role of liver inflammation in the pathogenesis of insulin resistance 61
Totale 9.954
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.659
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.659
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019412 0 0 0 0 0 0 0 0 0 0 222 190
2019/20201.954 408 95 91 69 129 165 231 108 117 173 178 190
2020/20211.515 89 166 77 172 190 63 159 32 194 70 271 32
2021/20221.730 69 162 46 174 119 43 29 282 62 86 317 341
2022/20233.615 481 475 278 534 264 433 156 331 419 45 145 54
2023/20241.391 119 528 70 81 72 256 109 64 23 69 0 0
Totale 14.256